List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antibody Revenue
1.4 Market Analysis by Type
1.4.1 Global Antibody Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 IgM
1.4.3 IgG
1.4.4 IgA
1.5 Market by Application
1.5.1 Global Antibody Market Share by Application: 2022-2027
1.5.2 Therapeutic
1.5.3 Research
1.5.4 Diagnostic
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Antibody Market
1.8.1 Global Antibody Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Antibody Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Antibody Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibody Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibody Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Antibody Sales Volume Market Share by Region (2016-2021)
3.2 Global Antibody Sales Revenue Market Share by Region (2016-2021)
3.3 North America Antibody Sales Volume
3.3.1 North America Antibody Sales Volume Growth Rate (2016-2021)
3.3.2 North America Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Antibody Sales Volume
3.4.1 East Asia Antibody Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Antibody Sales Volume (2016-2021)
3.5.1 Europe Antibody Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Antibody Sales Volume (2016-2021)
3.6.1 South Asia Antibody Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Antibody Sales Volume (2016-2021)
3.7.1 Southeast Asia Antibody Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Antibody Sales Volume (2016-2021)
3.8.1 Middle East Antibody Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Antibody Sales Volume (2016-2021)
3.9.1 Africa Antibody Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Antibody Sales Volume (2016-2021)
3.10.1 Oceania Antibody Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Antibody Sales Volume (2016-2021)
3.11.1 South America Antibody Sales Volume Growth Rate (2016-2021)
3.11.2 South America Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Antibody Sales Volume (2016-2021)
3.12.1 Rest of the World Antibody Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Antibody Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Antibody Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Antibody Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Antibody Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Antibody Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Antibody Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Antibody Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Antibody Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Antibody Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Antibody Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Antibody Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Antibody Sales Volume Market Share by Type (2016-2021)
14.2 Global Antibody Sales Revenue Market Share by Type (2016-2021)
14.3 Global Antibody Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Antibody Consumption Volume by Application (2016-2021)
15.2 Global Antibody Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Antibody Business
16.1 Roche
16.1.1 Roche Company Profile
16.1.2 Roche Antibody Product Specification
16.1.3 Roche Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Johnson & Johnson
16.2.1 Johnson & Johnson Company Profile
16.2.2 Johnson & Johnson Antibody Product Specification
16.2.3 Johnson & Johnson Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Merck
16.3.1 Merck Company Profile
16.3.2 Merck Antibody Product Specification
16.3.3 Merck Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Novartis
16.4.1 Novartis Company Profile
16.4.2 Novartis Antibody Product Specification
16.4.3 Novartis Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 AbbVie
16.5.1 AbbVie Company Profile
16.5.2 AbbVie Antibody Product Specification
16.5.3 AbbVie Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Amgen
16.6.1 Amgen Company Profile
16.6.2 Amgen Antibody Product Specification
16.6.3 Amgen Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Pfizer
16.7.1 Pfizer Company Profile
16.7.2 Pfizer Antibody Product Specification
16.7.3 Pfizer Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Bayer
16.8.1 Bayer Company Profile
16.8.2 Bayer Antibody Product Specification
16.8.3 Bayer Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Lilly
16.9.1 Lilly Company Profile
16.9.2 Lilly Antibody Product Specification
16.9.3 Lilly Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Bristol-Myers Squibb
16.10.1 Bristol-Myers Squibb Company Profile
16.10.2 Bristol-Myers Squibb Antibody Product Specification
16.10.3 Bristol-Myers Squibb Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 GlaxoSmithKline
16.11.1 GlaxoSmithKline Company Profile
16.11.2 GlaxoSmithKline Antibody Product Specification
16.11.3 GlaxoSmithKline Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Biogen
16.12.1 Biogen Company Profile
16.12.2 Biogen Antibody Product Specification
16.12.3 Biogen Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 AstraZeneca
16.13.1 AstraZeneca Company Profile
16.13.2 AstraZeneca Antibody Product Specification
16.13.3 AstraZeneca Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Sanofi
16.14.1 Sanofi Company Profile
16.14.2 Sanofi Antibody Product Specification
16.14.3 Sanofi Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Alexion Pharmaceuticals
16.15.1 Alexion Pharmaceuticals Company Profile
16.15.2 Alexion Pharmaceuticals Antibody Product Specification
16.15.3 Alexion Pharmaceuticals Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Seattle Genetics
16.16.1 Seattle Genetics Company Profile
16.16.2 Seattle Genetics Antibody Product Specification
16.16.3 Seattle Genetics Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Antibody Manufacturing Cost Analysis
17.1 Antibody Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Antibody
17.4 Antibody Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Antibody Distributors List
18.3 Antibody Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Antibody (2022-2027)
20.2 Global Forecasted Revenue of Antibody (2022-2027)
20.3 Global Forecasted Price of Antibody (2016-2027)
20.4 Global Forecasted Production of Antibody by Region (2022-2027)
20.4.1 North America Antibody Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Antibody Production, Revenue Forecast (2022-2027)
20.4.3 Europe Antibody Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Antibody Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Antibody Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Antibody Production, Revenue Forecast (2022-2027)
20.4.7 Africa Antibody Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Antibody Production, Revenue Forecast (2022-2027)
20.4.9 South America Antibody Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Antibody Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Antibody by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Antibody by Country
21.2 East Asia Market Forecasted Consumption of Antibody by Country
21.3 Europe Market Forecasted Consumption of Antibody by Countriy
21.4 South Asia Forecasted Consumption of Antibody by Country
21.5 Southeast Asia Forecasted Consumption of Antibody by Country
21.6 Middle East Forecasted Consumption of Antibody by Country
21.7 Africa Forecasted Consumption of Antibody by Country
21.8 Oceania Forecasted Consumption of Antibody by Country
21.9 South America Forecasted Consumption of Antibody by Country
21.10 Rest of the world Forecasted Consumption of Antibody by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
